Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.
In this piece, I highlight one particular talk that caught my interest — given by Elana Fertig, Dean E. Albert Reece Endowed Professor of Medicine at the University of Maryland. Fertig’s talk centered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results